Genetic Risk Factors in Drug?Induced Liver Injury Due to Isoniazid?Containing Antituberculosis Drug Regimens
(2020)
Journal Article
Drug?induced liver injury (DILI) is a complication of treatment with anti?tuberculosis (TB) drugs, especially in isoniazid?containing regimens. To investigate genetic risk factors, we performed a genome?wide association study (GWAS) involving anti?TB... Read More about Genetic Risk Factors in Drug?Induced Liver Injury Due to Isoniazid?Containing Antituberculosis Drug Regimens.